Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Terrault, Norah A., Lok, Anna S.F., McMahon, Brian J., Chang, Kyong‐Mi, Hwang, Jessica P., Jonas, Maureen M., Brown, Robert S., Bzowej, Natalie H. +1 more·2018·Hepatology
DOI 10.1002/hep.29800

Cites (274)

Items 201–274 of 274

  1. Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    2011 · PubMed
  2. Rescue therapy for lamivudine‐resistant chronic hepatitis B: Comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add‐on lamivudine combination therapy
    Hong Joo Kim, Jung Ho Park, Dong Il Park · 2010 · Journal of Gastroenterology and Hepatology
  3. Clinical course of 161 untreated and tenofovir‐treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region
    Golasa Samadi Kochaksaraei, Eliana Castillo, Mariam Osman · 2015 · Journal of Viral Hepatitis
  4. Immunizations in Chronic Liver Disease: What Should be Done and What is the Evidence
    Michael D. Leise, Jayant A. Talwalkar · 2012 · Current Gastroenterology Reports
  5. A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults
    Gregory D. Huhn, Pablo Tebas, Joel E. Gallant et al. · 2016 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  6. HB Vaccination in the Prevention of Viral Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients with Previous HBV Infection
    Masahiro Onozawa, Satoshi Hashino, Stephanie Darmanin et al. · 2008 · Transplantation and Cellular Therapy
  7. Treatment of Chronic Hepatitis D Patients with Pegylated Interferon: A Real-World Experience
    Zaigham Abbas, Mohammad Sadik Memon, Hammad Mithani · 2013 · Antiviral Therapy
  8. Updated CDC recommendations for the management of hepatitis B virus-infected health-care providers and students.
    2012 · PubMed
  9. Immunogenicity and safety of two schedules of Hepatitis B vaccination during pregnancy
    Indu Gupta, Radha Kanta Ratho · 2003 · Journal of obstetrics and gynaecology research
  10. Interaction Between Hepatitis B Virus and Alcohol Consumption in Liver Cirrhosis
    G Chevillotte, J.P. Durbec, André Gerolami · 1983 · Gastroenterology
  11. Extended Lamivudine Therapy against Hepatitis B Virus Infection in Hematopoietic Stem Cell Transplant Recipients
    Liang‐Tsai Hsiao, Tzeon-Jye Chiou, Liu H et al. · 2006 · Transplantation and Cellular Therapy
  12. Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?
    Aya Nakaya, Shinya� Fujita, Atsushi� Satake et al. · 2016 · Leukemia Research
  13. Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients
    Kavita Radhakrishnan, Aileen Chi, David J. Quan · 2017 · Transplantation
  14. Molecular diagnosis and treatment of drug-resistant hepatitis B virus
    Jeong Han Kim · 2014 · World Journal of Gastroenterology
  15. The use of lamivudine for patients with acute hepatitis B (a series of cases)
    Loreta Anesti Kondili, Husam Kamal Eldin Osman, David Mutimer · 2004 · Journal of Viral Hepatitis
  16. Hepatitis B virus reactivation after withdrawal of prophylactic antiviral therapy in patients with diffuse large B cell lymphoma
    Weiping Liu, Xiao Pei Wang, Wen Zheng · 2016 · Leukemia & lymphoma/Leukemia and lymphoma
  17. Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center
    Jessica Park Hwang, Michael Jordan Fisch, Anna Suk-Fong Lok · 2013 · BMC Cancer
  18. Serum Aminotransferase Flares in Pregnant and Postpartum Women With Current or Prior Treatment for Chronic Hepatitis B
    Christine Y. Chang, Natali Aziz, Mugilan Poongkunran · 2017 · Journal of Clinical Gastroenterology
  19. Picornavirus proteins share antigenic determinants with heat shock proteins 60/65
    Taina Härkönen, Mirja H. Puolakkainen, Matti Sarvas, Ulla Airaksinen, Tapani Hovi, Merja Roivainen · 2000 · Journal of Medical Virology
  20. Efficacy of an Accelerated Hepatitis B Vaccination Program During Pregnancy
    Jeanne S. Sheffield, Ashley Hickman, Jennifer C. Tang · 2011 · Obstetrics and Gynecology
  21. Vaccination Against Hepatitis B Virus (HBV) in HIV-1–Infected Patients With Isolated Anti–HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study
    Lionel Piroth, Odile Launay, Marie‐Louise Michel et al. · 2016 · The Journal of Infectious Diseases
  22. Hepatitis B virus infection and immunosuppressive therapy in patients with inflammatory bowel disease
    Filomena Morisco, Fabiana Castiglione, Antonio Rispo et al. · 2010 · Digestive and Liver Disease
  23. Risk of Hepatitis B Transmission After Amniocentesis in Chronic Hepatitis B Carriers
    James M. Alexander, Ronald M. Ramus, Gregory Jackson · 1999 · Infectious Diseases in Obstetrics and Gynecology
  24. Poor Recognition of Risk Factors for Hepatitis B by Physicians Prescribing Immunosuppressive Therapy: A Call for Universal Rather than Risk-Based Screening
    Alissa Visram, Kelvin Chan, Phyllis McGee · 2015 · PLoS ONE
  25. Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: Meta-analysis
    Xiaoguang Ye · 2013 · World Journal of Gastroenterology
  26. Tenofovir alafenamide demonstrates broad cross-genotype activity against wild-type HBV clinical isolates and maintains susceptibility to drug-resistant HBV isolates in vitro
    Yang Liu, Michael D. Miller, Kathryn M. Kitrinos · 2016 · Antiviral Research
  27. Review of the use of hepatitis B core antibody–positive kidney donors
    Rosemary Ouseph, Mary Eng, Kadiyala V. Ravindra · 2010 · Transplantation Reviews
  28. In Utero Tenofovir Exposure Is not Associated With Fetal Long Bone Growth
    Jennifer K. Jao, Elaine J. Abrams, Tamsin K. Phillips · 2016 · Clinical Infectious Diseases
  29. Polyomavirus microRNAs circulating in biological fluids during viral persistence
    Francesco Martelli, Simone Giannecchini · 2017 · Reviews in Medical Virology
  30. Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
    Jihye Park, Kyu Sik Jung, Hye Won Lee, Seung Up Kim, Do Young Kim, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Jun Yong Park · 2017 · Gut and Liver
  31. Hepatitis B virus ( HBV ) reverse seroconversion ( RS ) can be prevented even in non‐responders to hepatitis B vaccine after allogeneic stem cell transplantation: long‐term analysis of intervention in RS with vaccine for patients with previous HBV infection
    Mutsumi Takahata, Satoshi Hashino, Masahiro Onozawa et al. · 2014 · Transplant Infectious Disease
  32. Add-On Adefovir Is Superior to a Switch to Entecavir as Rescue Therapy for Lamivudine-Resistant Chronic Hepatitis B
    Goh Eun Chung, Won Kyum Kim, Kook Lae Lee et al. · 2011 · Digestive Diseases and Sciences
  33. Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma
    Mario Masarone, Amalia De Renzo, Vincenzo La Mura · 2014 · BMC Gastroenterology
  34. Efficacy and safety of entecavir and/or tenofovir in hepatitis B compensated and decompensated cirrhotic patients in clinical practice
    Mireia Miquel, Óscar Núñez Martínez, María Trapero-Marugán · 2013 · Annals of Hepatology
  35. Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus
    Yu Jin Kim, Jin Woo Lee, Yun Soo Kim · 2011 · The Korean Journal of Hepatology
  36. Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B
    Jieyao Cheng, Jinlin Hou, Huiguo Ding, Guofeng Chen, Qing Xie, Yuming Wang, Minde Zeng, Xiaojuan Ou, Hong Ma, Jidong Jia · 2015 · PLoS ONE
  37. Children with Chronic Hepatitis B in the United States and Canada
    Kathleen B. Schwarz, Kathleen B. Schwarz, Yona Keich Cloonan et al. · 2015 · The Journal of Pediatrics
  38. Meta-analysis of prophylactic entecavir or lamivudine against hepatitis B virus reactivation.
    Chun Yang, Bo Qin, Zhe Yuan · 2017 · PubMed
  39. Excellent Outcome of Lamivudine Treatment in Patients With Chronic Renal Failure and Hepatitis B Virus Infection
    Hemda Schmilovitz‐Weiss, Ehud Melzer, Ran Tur‐Kaspa · 2003 · Journal of Clinical Gastroenterology
  40. Why, When, and How to Prevent Hepatitis B Virus Reactivation in Cancer Patients Undergoing Chemotherapy
    Bhumsuk Keam, Jeong‐Hoon Lee, Seock‐Ah Im · 2011 · Journal of the National Comprehensive Cancer Network
  41. Comparison of entecavir and lamivudine in preventing HBV reactivation in lymphoma patients undergoing chemotherapy: a meta-analysis
    Sisi Yu, Huaichao Luo, Meiling Pan · 2016 · International Journal of Clinical Pharmacy
  42. Low Prevalence of Ongoing Hepatitis B Viremia in HIV-Positive Individuals with Isolated Antibody to Hepatitis B Core Antigen
    Rajesh Tim Gandhi, Alysse Gail Wurcel, Barbara G. McGovern et al. · 2003 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  43. Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis
    Filomena Morisco, Maria Guarino, Serena La Bella · 2014 · BMC Gastroenterology
  44. The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis.
    Εvangelos Cholongitas, George Papatheodoridis, John Goulis · 2015 · PubMed
  45. Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection
    Paolo DE SIMONE, Renato Romagnoli, Francesco Tandoi et al. · 2016 · Transplantation
  46. Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor
    Carlotta Cerva, Luna Colagrossi, Gaetano Maffongelli et al. · 2016 · Clinical Microbiology and Infection
  47. Evolution in Our Understanding of Hepatitis B Virus Virology and Immunology
    Bertram Bengsch, Kyong‐Mi Chang · 2016 · Clinics in Liver Disease
  48. Comparison of the Efficacy of Lamivudine Plus Adefovir Versus Entecavir in the Treatment of Lamivudine-Resistant Chronic Hepatitis B: A Systematic Review and Meta-Analysis
    Zebing Huang, Shushan Zhao, Yan Huang et al. · 2013 · Clinical Therapeutics
  49. Growth at 2 Years of Age in HIV-exposed Uninfected Children in the United States by Trimester of Maternal Antiretroviral Initiation
    Denise L. Jacobson, Kunjal Patel, Paige L. Williams, Mitchell E. Geffner, George Kelly Siberry, Linda Anne DiMeglio, Marilyn J. Crain, Ayesha Mirza, Janet S. Chen, Elizabeth J. McFarland et al. · 2016 · The Pediatric Infectious Disease Journal
  50. Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort Study
    Jessica Park Hwang, Anna Suk-Fong Lok, Michael Jordan Fisch et al. · 2018 · Journal of Clinical Oncology
  51. Efficacy of entecavir treatment for lamivudine‐resistant hepatitis B over 3 years: Histological improvement or entecavir resistance?
    Yoshiyuki Suzuki, Fumitaka Suzuki, Yusuke Kawamura et al. · 2009 · Journal of Gastroenterology and Hepatology
  52. Individualizing hepatitis B infection prophylaxis in liver transplant recipients
    Alyson N. Fox, Norah A. Terrault · 2011 · Journal of Hepatology
  53. Telbivudine versus lamivudine and entecavir for treatment-naïve decompensated hepatitis B virus-related cirrhosis
    Yue‐Meng Wan, Yuhua Li, Hua-Mei Wu · 2016 · Clinical and Experimental Medicine
  54. Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis
    Soon Kyu Lee, Myeong Jun Song, Seok Hyun Kim et al. · 2017 · World Journal of Gastroenterology
  55. Mediation Analysis of Hepatitis B and C in Relation to Hepatocellular Carcinoma Risk
    Yen‐Tsung Huang, Hwai‐I Yang, Jessica Liu · 2015 · Epidemiology
  56. Pretransplant Hepatitis B Viral Infection Increases Risk of Death After Kidney Transplantation
    Jeonghwan Lee, Jang‐Hee Cho, Jong‐Soo Lee et al. · 2016 · Medicine
  57. Comparison of Enzyme Immunoassays for Detection of Antibodies to Hepatitis D Virus in Serum
    Siu-Kei Chow, Ederlyn E. Atienza, Linda Cook · 2016 · Clinical and Vaccine Immunology
  58. Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection
    Li Wang, Zhiqiang Zou, Kai Wang · 2015 · Hepatology International
  59. Adding adefovir vs. switching to entecavir for lamivudine‐resistant chronic hepatitis B ( ACE study): a 2‐year follow‐up randomized controlled trial
    Hyung Joon Yim, Yeon Seok Seo, Eileen Laureal Yoon et al. · 2012 · Liver International
  60. Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside‐naïve HBeAg‐positive patients with chronic hepatitis B
    Ting‐Tsung Chang, You‐Chen Chao, V V Gorbakov · 2009 · Journal of Viral Hepatitis
  61. A phase 3 study comparing tenofovir alafenamide (TAF) to tenofovir disoproxil fumarate (TDF) in patients with HBeAg-positive, chronic hepatitis B (CHB): efficacy and safety results at week 96
    Kosh Agarwal, Scott K. Fung, Wai‐Kay Seto et al. · 2017 · Journal of Hepatology
  62. Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection
    J.‐H. Cho, Jong‐Hwan Lim, G.‐Y. Park et al. · 2014 · Transplant Infectious Disease
  63. A Retrospective Study on the Significance of Liver Biopsy and Hepatitis B Surface Antigen in Chronic Hepatitis B Infection
    Dawu Zeng, Jiemin Zhang, Yu-Rui Liu · 2016 · Medicine
  64. The efficacy and safety of entecavir in patients with chronic hepatitis B- associated liver failure: a meta-analysis
    Xiaoguo Zhang, Lu Liu, Meng Zhang · 2015 · Annals of Hepatology
  65. Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment
    Anna Suk-Fong Lok, Lilia Milkova Ganova-Raeva, Yona Keich Cloonan · 2017 · Journal of Viral Hepatitis
  66. Co-infection with hepatitis B does not alter treatment response in chronic hepatitis C
    Ahmet UYANIKOĞLU, Filiz Akyüz, Bülent Baran · 2013 · Clinics and Research in Hepatology and Gastroenterology
  67. Entecavir for Patients with Hepatitis B Decompensated Cirrhosis in China: a meta-analysis
    F. Y. Wang, Baohu Li, Y. Li · 2016 · Scientific Reports
  68. DETECTION OF HEPATITIS B VIRUS DNA IN ASYMPTOMATIC HEPATITIS B SURFACE ANTIGEN CARRIERS: RELATION TO SEXUAL TRANSMISSION
    Nicolaos C. Tassopoulos, GEORGE J. PAPAEVANGELOU, Anastasia J. Roumeliotou‐Karayannis · 1987 · American Journal of Epidemiology
  69. Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection
    Angelo Iacobellis, Angelo Andriulli · 2009 · Expert Opinion on Pharmacotherapy
  70. Factors associated with HBV Virological Breakthrough
    Suzanne Sheppard‐Law, Iryna Zablotska, Melissa Kermeen · 2016 · Antiviral Therapy
  71. Efficacy of Tenofovir-based Rescue Therapy in Lamivudine-resistant Chronic Hepatitis B Patients With Failure of Lamivudine and Adefovir Combination
    Jae Ho Park, Seok Won Jung, Neung Hwa Park et al. · 2015 · Clinical Therapeutics
  72. Hepatitis B surface antigen loss: Not all that we hoped it would be
    Michael H. Nathanson, Norah A. Terrault · 2016 · Hepatology
  73. Letter to the Editor
    Gilbert G.G. Donders · 1999 · Infectious Diseases in Obstetrics and Gynecology
  74. Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma ‐ authors' reply
    Prabhu P. Gounder, LISA R. BULKOW, Brian J. McMahon · 2016 · Alimentary Pharmacology & Therapeutics